NAMS
Price
$32.99
Change
-$0.02 (-0.06%)
Updated
Feb 3 closing price
Capitalization
3.74B
28 days until earnings call
Intraday BUY SELL Signals
QURE
Price
$27.80
Change
-$35.85 (-56.32%)
Updated
Feb 3 closing price
Capitalization
1.73B
26 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NAMS vs QURE

Header iconNAMS vs QURE Comparison
Open Charts NAMS vs QUREBanner chart's image
NewAmsterdam Pharma
Price$32.99
Change-$0.02 (-0.06%)
Volume$612.74K
Capitalization3.74B
uniQure
Price$27.80
Change-$35.85 (-56.32%)
Volume$4.68M
Capitalization1.73B
NAMS vs QURE Comparison Chart in %
NAMS
Daily Signal:
Gain/Loss:
QURE
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
NAMS vs. QURE commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NAMS is a Hold and QURE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (NAMS: $32.99 vs. QURE: $27.80)
Brand notoriety: NAMS and QURE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NAMS: 73% vs. QURE: 190%
Market capitalization -- NAMS: $3.74B vs. QURE: $1.73B
NAMS [@Biotechnology] is valued at $3.74B. QURE’s [@Biotechnology] market capitalization is $1.73B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NAMS’s FA Score shows that 1 FA rating(s) are green whileQURE’s FA Score has 0 green FA rating(s).

  • NAMS’s FA Score: 1 green, 4 red.
  • QURE’s FA Score: 0 green, 5 red.
According to our system of comparison, both NAMS and QURE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NAMS’s TA Score shows that 5 TA indicator(s) are bullish while QURE’s TA Score has 6 bullish TA indicator(s).

  • NAMS’s TA Score: 5 bullish, 2 bearish.
  • QURE’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, both NAMS and QURE are a good buy in the short-term.

Price Growth

NAMS (@Biotechnology) experienced а +1.10% price change this week, while QURE (@Biotechnology) price change was +14.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Reported Earning Dates

NAMS is expected to report earnings on Mar 04, 2026.

QURE is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NAMS($3.74B) has a higher market cap than QURE($1.73B). QURE YTD gains are higher at: 16.172 vs. NAMS (-5.958). QURE has higher annual earnings (EBITDA): -146.3M vs. NAMS (-268.03M). NAMS (703M) and QURE (694M) have equal amount of cash in the bank . NAMS has less debt than QURE: NAMS (266K) vs QURE (66.2M). NAMS has higher revenues than QURE: NAMS (35.2M) vs QURE (15.8M).
NAMSQURENAMS / QURE
Capitalization3.74B1.73B216%
EBITDA-268.03M-146.3M183%
Gain YTD-5.95816.172-37%
P/E RatioN/AN/A-
Revenue35.2M15.8M223%
Total Cash703M694M101%
Total Debt266K66.2M0%
FUNDAMENTALS RATINGS
QURE: Fundamental Ratings
QURE
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
90
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NAMSQURE
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
56%
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
57%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
55%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 6 days ago
71%
Bearish Trend 8 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
NAMS
Daily Signal:
Gain/Loss:
QURE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PJRQX10.340.08
+0.78%
PGIM Quant Solutions International Eq R6
MXPBX13.74N/A
N/A
Empower International Index Instl
BAUUX28.19-0.05
-0.18%
Brown Advisory Small-Cap Fdmtl Val Instl
VGHAX86.45-0.67
-0.77%
Vanguard Health Care Adm
ESGEX21.12-0.22
-1.03%
Reynders McVeigh Core Equity Instl

NAMS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAMS has been loosely correlated with IMVT. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if NAMS jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAMS
1D Price
Change %
NAMS100%
+4.50%
IMVT - NAMS
45%
Loosely correlated
-1.07%
DYN - NAMS
42%
Loosely correlated
+1.07%
ROIV - NAMS
42%
Loosely correlated
+0.14%
CRDF - NAMS
41%
Loosely correlated
-1.75%
IMTX - NAMS
40%
Loosely correlated
-0.40%
More

QURE and

Correlation & Price change

A.I.dvisor indicates that over the last year, QURE has been loosely correlated with NEVPF. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if QURE jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QURE
1D Price
Change %
QURE100%
+12.55%
NEVPF - QURE
50%
Loosely correlated
N/A
AXON - QURE
42%
Loosely correlated
-1.89%
BCYC - QURE
38%
Loosely correlated
-7.55%
LXEO - QURE
38%
Loosely correlated
-1.57%
NAMS - QURE
38%
Loosely correlated
+4.50%
More